Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients

Ain Shams University135 enrolled

Overview

The aim of this study will be to investigate the efficacy of use of combination of Ivermectin and colchicine on severity and outcome Of COVID 19 infection.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

135

Conditions

COVID-19

Interventions

Ivermectin + colchicineDRUG

In addition to the local standard of care for COVID 19 patients, the patient will receive Ivermectin + colchicine

ColchicineDRUG

In addition to the local standard of care for COVID 19 patients, the patient will receive colchicine

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Willing and able to provide written informed consent prior to performing study procedures. * Currently hospitalized and requiring medical care for non-sever COVID-19. * One or more of the following: (positive PCR test or positive antibodies) or (CT Chest consistent with COVID19 infection). Exclusion Criteria: * Tocilizumab use. * Mechanical ventilation * Requirement of oxygen supplementation \>8L/min on admission

Locations (1)

Ain Shams University hospitals

Cairo, Egypt

Outcomes

Primary Outcomes

length of oxygen requirement

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.